Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Impact of concurrent (CON) and sequential (SEQ)...
Journal article

Impact of concurrent (CON) and sequential (SEQ) radiotherapy (RT) with adjuvant aromatase inhibitors (AI) in early-stage breast cancer (EBC): NCIC CTG MA.27.

Abstract

500 Notice of Retraction: "Impact of concurrent (CON) and sequential (SEQ) radiotherapy (RT) with adjuvant aromatase inhibitors (AI) in early-stage breast cancer (EBC): NCIC CTG MA.27."

Authors

Altwairgi AK; Parulekar W; Chapman J-AW; Shepherd LE; Pritchard KI; Han L; Goss PE; Whelan TJ

Journal

Journal of Clinical Oncology, Vol. 30, No. 15_suppl, pp. 500–500

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2012

DOI

10.1200/jco.2012.30.15_suppl.500

ISSN

0732-183X